T Cell News and Research

Latest T Cell News and Research

Researchers uncover new mechanism of how Ebola viruses escape immune system

A research team from Tübingen and Göttingen has described in the renowned journal Cell Reports a new mechanism how the Ebola virus escapes the immune system.

12 Feb 2019

Scientists discover new mechanism by which sleep supports the immune system

Getting enough sleep is vital to supporting our immune system in fighting off pathogens - so much is common knowledge. But what we don't know is how exactly sleep affects certain immune functions.

12 Feb 2019

Marine snail venom reveals clues to developing faster-acting insulin for diabetic patients

Although moderately mobile, marine cone snails have perfected several strategies to capture prey. Some fish-hunting species release venom into the surrounding water.

12 Feb 2019

New diagnostic technique reveals key protein biomarker for bladder cancer

Label-free digital pathology using infrared imaging with subsequent proteomic analysis for bladder cancer has revealed the first protein biomarker for BC. AHNAK2 differentiates between chronic cystitis (inflammation of the bladder) and a non-muscle invasive-type BC (carcinoma in situ) which is challenging to diagnose.

12 Feb 2019

Lactate activates multiple genes that modulate neuronal activity

A genome-wide study led by Dean Pierre Magistretti sheds light on the mechanisms through which lactate regulates long-term memory formation and neuroprotection.

12 Feb 2019

Pill that reverses brain damage could be on the horizon

Researchers have made important progress in designing a drug that could recover brain function in cases of severe brain damage due to injury or disease.

12 Feb 2019

Over-abundance of energy to cells could increase cancer risk

It's well-known that obesity, diabetes and chronic inflammation are major risk factors for cancer. But just how cancer evolves in people with these diseases -- and why a healthy diet and exercising regularly can help prevent it -- is poorly understood.

12 Feb 2019

Study reveals how one mutation causes the most common inherited intellectual disability

Research published today (Feb. 11, 2019) reveals how one mutation causes fragile X, the most common inherited intellectual disability.

12 Feb 2019

New bioengineered device enhances the production of T-cells

Bone marrow transplants, also known as hematopoietic stem cell transplants, are life-saving treatments for aggressive diseases, such as leukemia and multiple myeloma, and infections such as HIV. The procedure entails infusion of blood stem cells from a matched donor into the patient to 'reset' the blood and immune system.

12 Feb 2019

NIH scientists zero in on genes associated with AMD

National Eye Institute scientists led a collaborative study and zeroed in on genes associated with age-related macular degeneration, a leading cause of vision loss and blindness among people age 65 and older.

12 Feb 2019

Antibody-based treatment could improve cure rate for blood and immune disorders

An antibody-based treatment can gently and effectively eliminate diseased blood-forming stem cells in the bone marrow to prepare for the transplantation of healthy stem cells, according to a study in mice by researchers at the Stanford University School of Medicine.

12 Feb 2019

Rare gene mutations associated with colorectal cancer also cause breast cancer

Rare mutations in the NTHL1 gene, previously associated with colorectal cancer, also cause breast cancer and other types of cancer.

12 Feb 2019

Inhibiting tuberculosis-induced cell death with immunotherapy

Tuberculosis treatment still entails the intake several antibiotics over a period of many months and is torturous for many patients. The pathogen's increasing multidrug resistance additionally complicates this lengthy treatment, and side effects frequently lead to a discontinuation of treatment and high mortality rates.

12 Feb 2019

AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma

AbbVie, Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that they have entered a global strategic transaction to develop and commercialize TNB-383B, a BCMA-targeting immunotherapeutic for the potential treatment of multiple myeloma.

12 Feb 2019

Researchers discover new therapeutic target for rare, aggressive pediatric cancers

Researchers at The University of Texas MD Anderson Cancer Center have discovered that malignant rhabdoid tumors, a rare pediatric cancer without effective treatments, may be sensitive to drugs that block the cancer cell's ability to dispose of misfolded proteins.

12 Feb 2019

UMN researchers develop new way to study cancer cells in a 3D in vitro model

University of Minnesota researchers have developed a way to study cancer cells which could lead to new and improved treatment. They have developed a new way to study these cells in a 3D in vitro model (i.e. in a culture dish rather than in a human or animal).

12 Feb 2019

Cancer-promoting changes seen in lung cells soon after exposure to low-molecular weight PAHs

It is well known that exposure to high-molecular weight polycyclic aromatic hydrocarbons increases cancer risk, leading to regulation of compounds like benzo(a)pyrene.

12 Feb 2019

Researchers to investigate light therapy as relief from painful side effect of cancer treatment

University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.

12 Feb 2019

Human brain protein linked with autism has an effect on fruit fly behavior

A mutant gene that encodes a brain protein in a child with autism has been placed into the brains of fruit flies. Fruit flies hosting that gene produce the variant human brain protein and show abnormal behaviors of fear, repetitive activity and altered social interaction, reminiscent of autism impairments.

12 Feb 2019

New PET imaging agent may help measure efficacy or failure of hormone therapy for breast cancer

Physicians may soon have a new way to measure the efficacy or failure of hormone therapy for breast cancer patients, according to new research published in the February issue of The Journal of Nuclear Medicine.

12 Feb 2019

T Cell News and Research

Latest T Cell News and Research

Researchers uncover new mechanism of how Ebola viruses escape immune system

Scientists discover new mechanism by which sleep supports the immune system

Marine snail venom reveals clues to developing faster-acting insulin for diabetic patients

New diagnostic technique reveals key protein biomarker for bladder cancer

Lactate activates multiple genes that modulate neuronal activity

Pill that reverses brain damage could be on the horizon

Over-abundance of energy to cells could increase cancer risk

Study reveals how one mutation causes the most common inherited intellectual disability

New bioengineered device enhances the production of T-cells

NIH scientists zero in on genes associated with AMD

Antibody-based treatment could improve cure rate for blood and immune disorders

Rare gene mutations associated with colorectal cancer also cause breast cancer

Inhibiting tuberculosis-induced cell death with immunotherapy

AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma

Researchers discover new therapeutic target for rare, aggressive pediatric cancers

UMN researchers develop new way to study cancer cells in a 3D in vitro model

Cancer-promoting changes seen in lung cells soon after exposure to low-molecular weight PAHs

Researchers to investigate light therapy as relief from painful side effect of cancer treatment

Human brain protein linked with autism has an effect on fruit fly behavior

New PET imaging agent may help measure efficacy or failure of hormone therapy for breast cancer

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in